Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin
Ilir Maraj1,2*, James P Hummel1*, Roy Taoutel1, Romy Chamoun1, Virginia Workman1, Cindy Li3, Lydia Tran3, Alexander DelVecchio2, Christopher Howes1,2, Joseph G Akar1,2
  1. Department of Internal Medicine, Cardiovascular Medicine, Yale School of Medicine, New Haven, CT
  2. Department of Internal Medicine, Greenwich Hospital, Greenwich, CT
  3. Department of Pharmacy Services, Yale New Haven Hospital, New Haven, CT
*Authors contributed equally